We used an S. aureus strain isolated from a hospital in a previous study by our group, which has norA, mecA and blaZ genes, respectively, resistant to fluoroquinolone and beta-lactams (Carvalho et al., 2017). We used Brain Heart Infusion (BHI) and mannitol agar to activate, cultivate and sub-cultivate S. aureus strains for further inoculation in MPMs and HPBMs. In addition, Gram stain, catalase test, coagulase test and PCR (nuc gene) (Sasaki et al., 2010) were performed to confirm the identity and purity of the bacterial strain.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.